A recent study specifically focused on the impact of 9p loss in grade II and III glioma and found that loss of 9p is an independent prognostic factor in IDH mutated glioma, however, the effect was most clear in IDH mutated astrocytomas [11]. This evidence concerns the gene IDH1 and central nervous system cancer.